25.1.2008   

EN

Official Journal of the European Union

C 19/12


Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2007 to 31 December 2007

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council  (1) or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council  (2) )

(2008/C 19/05)

—   Issuing, maintenance or modification of a national marketing authorisation

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

18.12.2007

Tracleer

Actelion Registration Ltd

BSI Building 13th Floor

389 Chiswick High Road

London W4 4AL

United Kingdom

This Decision is addressed to the Member States

19.12.2007

18.12.2007

Silapo

STADA Arzneimittel AG

Stadastraße 2-18

D-61118 Bad Vilbel

This Decision is addressed to the Member States

19.12.2007

18.12.2007

Retacrit

HOSPIRA Enterprises B.V.

Taurusavenue 19-21b

2132 LS Hoofddorp

Nederland

This Decision is addressed to the Member States

19.12.2007

19.12.2007

MabCampath

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

Nederland

This Decision is addressed to the Member States

20.12.2007


(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.